Managing MS

Spinal Fluid Marker May Predict More Rapid MS Progression in People with Newly Diagnosed MS

Multiple Sclerosis (MS) is caused by the attack of the patient’s immune system on the coating of nerve fibers (myelin) in the Central Nervous System (brain and spinal cord). We also know that the nerve fibers themselves can be damaged, which causes even greater disability.   Researchers have identified a molecule in the spinal fluid […]

Spinal Fluid Marker May Predict More Rapid MS Progression in People with Newly Diagnosed MS Read More »

Is Ozempic OK for MS Patients?

More than just ok for MS patients, Ozempic may actually be beneficial to those who would have developed it. Recent studies have shown the potential neuroprotective effects of diabetes and weight loss drugs (called semaglutides) in different neurologic conditions, such as Parkinson’s Disease (https://becarelink.com/the-meds-americans-crave-for-weight-loss-may-benefit-patients-with-early-parkinsons-disease/). A study presented at a MS conference (Actrims) in 2024 showed

Is Ozempic OK for MS Patients? Read More »

MS Disability Progression Increases In patients with other Autoimmune Disorders

A recently published study suggests that MS patients are likely to have greater disability progression if they also carry diagnoses of other autoimmune disorders, such as Crohn’s disease, Ulcerative Colitis, and Type 1 Diabetes. The gold standard tool of measuring disability in MS is called the Expanded Disability Status Scale (EDSS).  The scale ranges from

MS Disability Progression Increases In patients with other Autoimmune Disorders Read More »

The Difference Between Advanced and Progressive Multiple Sclerosis

The most well-known type of Multiple Sclerosis is Relapsing-Remitting MS (RRMS) in which the patient experiences a distinct onset of symptoms and significant improvement of the symptoms as the flare remits.  As this is a chronic disorder, repeated flares can cause permanent damage and therefore long-term and permanent disability.  The longer someone lives with MS,

The Difference Between Advanced and Progressive Multiple Sclerosis Read More »

Does MS directly cause depression or is depression a reaction to having MS?

There has been a longstanding debate as to whether depression, which is noted exceedingly frequently in MS patients, is caused by the disease state (in other words biologically distinct from depression that occurs in other neurologic and psychiatric conditions) or is a co-morbidity of MS (meaning that MS and depression tend to occur together but

Does MS directly cause depression or is depression a reaction to having MS? Read More »

Imaging with PET Scans may reveal low-grade inflammation in MS patients

PET scans (Positron emission Tomography) is an imaging technique often used to detect the spread of cancer or changes in the brain associated with Alzheimer’s Disease. A recent publication reports that PET scans can reveal unsuspected smoldering inflammation in patients treated with disease-modifying treatments (DMT).  The existence of ongoing low-grade inflammation may help explain why

Imaging with PET Scans may reveal low-grade inflammation in MS patients Read More »

Skin Tests can detect some Neurodegenerative Disorders

Certain chronic neurodegenerative disorders, such as Parkinson’s Disease, have been linked to the presence of an abnormal form of a protein called alpha-synuclein. Approximately 2.5 million patients in the US suffer from synucleinopathies. Synucleinopathies are progressive neurodegenerative diseases, each with different prognoses.  Many often take years to diagnose as the initial signs are subtle and

Skin Tests can detect some Neurodegenerative Disorders Read More »

MS patients may feel depression as their Monoclonal Antibody Treatment “wears off”

While the “feel good effect” has long been associated with the use of the monoclonal antibody Natalizumab, there is now evidence that the wearing-off of this and other monoclonal antibodies is associated with depression.  In fact, more than half of MS patients treated with the monoclonal antibodies Ocrevus, Rituxan, and Natalizumab who were surveyed reported

MS patients may feel depression as their Monoclonal Antibody Treatment “wears off” Read More »

Gold may be Good for More than Jewelry for some Neurologic Patients

Patients with neurodegenerative disorders such as Multiple Sclerosis (MS) and Parkinson’s Disease (PD) may find hope in the most unlikely of resources: GOLD.  Researchers at the University of Texas Southwestern Medical Center have been testing the treatment of oral intake of gold nanocrystals in MS and PD patients suffering from problems in motor movement. MS

Gold may be Good for More than Jewelry for some Neurologic Patients Read More »